34E Exenatide utilization and effectiveness in a health plan population

Sunday, April 26, 2009
Rolin Wade, RPh, MS , HealthCore, Inc., Wilmington, DE
Brock Schroeder, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Ralph Quimbo, MA , HealthCore, Inc., Wilmington, DE
Derek Misurski, PhD , Eli Lilly and Company, Indianapolis, IN
Rosalind Fabunmi, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Loretta Nielsen, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Matthew Wintle, MD , Amylin Pharmaceuticals, Inc., San Diego, CA